Olema Pharmaceuticals OLMA
NASDAQ OLMA
$6.41 -0.61 (-8.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Olema Pharmaceuticals (OLMA) Cash & Current Investments (2020 - 2026)

Updated

Olema Pharmaceuticals' Cash & Current Investments came in at $461.07 million for Q2 2026, up 27.4% from $361.91 million a year earlier but down 8.8% from the prior quarter.

Analysis

Olema Pharmaceuticals (OLMA) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Olema Pharmaceuticals' Cash & Current Investments was $505.44 million, up 16.4% from FY2024.

  • Cash & Current Investments has increased in each of the last three years, with a five-year compound annual growth rate of 8.3% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $434.09 million in FY2024 (+65.8%), $261.81 million in FY2023 (+28.1%), $204.42 million in FY2022 (-28.8%) and $287.25 million in FY2021 (-15.2%).
  • The five-year range for quarterly Cash & Current Investments is $167.44 million (Q2 2023) to $505.44 million (Q4 2025).
  • Year-over-year, Cash & Current Investments has increased for seven consecutive quarters, with growth averaging 34.8% over the last eight quarters.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2024 (growth of 65.8%), and the weakest in Q1 2023 (a decline of 30.6%).
  • Business Quant data shows OLMA's Cash & Current Investments at $505.35 million (Q1 2026), $505.44 million (Q4 2025) and $328.96 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Olema Pharmaceuticals 677.90 Mn -1.12 Bn - 461.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 461.07 Mn
Mar 31, 2026 505.35 Mn
Dec 31, 2025 505.44 Mn
Sep 30, 2025 328.96 Mn
Jun 30, 2025 361.91 Mn
Mar 31, 2025 392.71 Mn
Dec 31, 2024 434.09 Mn
Sep 30, 2024 214.76 Mn
Jun 30, 2024 239.10 Mn
Mar 31, 2024 248.98 Mn
Dec 31, 2023 261.81 Mn
Sep 30, 2023 276.90 Mn
Jun 30, 2023 167.44 Mn
Mar 31, 2023 185.95 Mn
Dec 31, 2022 204.42 Mn
Sep 30, 2022 222.60 Mn
Jun 30, 2022 240.71 Mn
Mar 31, 2022 267.87 Mn
Dec 31, 2021 287.25 Mn
Sep 30, 2021 305.95 Mn
API Access

Olema Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=OLMA&period=max&api_key=YOUR_API_KEY